New pill tested to fight sickle cell disease
Disease control
Completed
This early-stage study tested the safety and effects of an experimental oral medication called FTX-6058 in adults with sickle cell disease. Forty-five participants took the daily pill for 12 weeks while researchers monitored for side effects and measured how the drug affected the…
Phase: PHASE1 • Sponsor: Fulcrum Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC